Related Experiment Video
Updated: Mar 6, 2026

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Vitiligo Pathogenesis and Emerging Treatments
Mehdi Rashighi1, John E Harris2
1Department of Dermatology, University of Massachusetts Medical School, Worcester, MA 01605, USA; Department of Dermatology, Tehran University of Medical Sciences, 415 Taleqani Avenue, Tehran 1416613675, Iran.
Abstract:
The pathogenesis of vitiligo involves interplay between intrinsic and extrinsic melanocyte defects, innate immune inflammation, and T-cell-mediated melanocyte destruction. The goal of treatment is to not only halt disease progression but also promote repigmentation through melanocyte regeneration, proliferation, and migration. Treatment strategies that address all aspects of disease pathogenesis and repigmentation are likely to have greatest efficacy, a strategy that may require combination therapies. Current treatments generally involve nontargeted suppression of autoimmunity, whereas emerging treatments are likely to use a more targeted approach based on in-depth understanding of disease pathogenesis, which may provide higher efficacy with a good safety profile.
Insights
Vitiligo treatment aims to stop disease progression and restore skin color by addressing melanocyte defects and immune responses. Emerging therapies focus on targeted approaches for better efficacy and safety.
Area of Science:
- Dermatology
- Immunology
- Cell Biology
Background:
- Vitiligo pathogenesis involves melanocyte defects, inflammation, and immune destruction.
- Current treatments often non-specifically suppress autoimmunity.
Purpose of the Study:
- To outline vitiligo pathogenesis and treatment goals.
- To discuss current and emerging therapeutic strategies.
Main Methods:
- Review of vitiligo pathogenesis mechanisms.
- Analysis of current and novel treatment approaches.
Main Results:
- Vitiligo involves complex interactions leading to melanocyte loss.
- Repigmentation requires melanocyte regeneration, proliferation, and migration.
Conclusions:
- Combination therapies addressing all pathogenic aspects may offer greatest efficacy.
- Targeted emerging treatments promise higher efficacy and improved safety profiles.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
iPS Cell Differentiation
Clinical Applications of Epidermal Stem Cells
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

